May 8, 2026 | life sciences
We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role in bringing together life sciences organizations across the North of the UK.

At a time when early‑stage innovation is advancing rapidly and development decisions can carry long‑term impact, strong regional networks like Bionow are essential for fostering progress and collective learning. We’re excited to be part of a network that supports connection and knowledge sharing across the region where we have a strong presence, including offices in Manchester, Bollington, Newcastle and Dundee.
With 300 team members worldwide, Amiculum works with life‑science companies across the globe from the early stages of drug development, helping teams shape clear, strategic foundations that support confident decision-making and drive faster, smoother progression through development milestones.
We’re looking forward to connecting with fellow members at upcoming Bionow events, including Demystifying and Navigating Health Economics & Regulatory Compliance in Manchester, the BioFocus 2026 conference in Newcastle next month, and the Bionow Neuroscience Conference 2026 in Sheffield this July.
To learn more about Amiculum and how we can support you, get in touch here: Amiculum | Contact
This content was provided by Amiculum
Latest Content from Amiculum
We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role in bringing together life sciences organizations across the North of the…
By Lottie Sequerra and Emily Morton-West
Amiculum is pleased to announce the relocation of its Dundee team to a new, state-of-the-art facility at the Dundee Life Sciences Innovation Hub, an environment designed to accelerate scientific progress…
By Zoë van Helmond
By Betty Charleshouse
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity…
